期刊
EMBO MOLECULAR MEDICINE
卷 3, 期 12, 页码 713-725出版社
WILEY
DOI: 10.1002/emmm.201100183
关键词
atherosclerosis; chemokine; inflammation; leukocyte; therapeutic
资金
- Deutsche Forschungsgemeinschaft (DFG) [FOR809]
In their role as small chemotactic cytokines, chemokines are crucial mediators and regulators of leukocyte trafficking during immune surveillance and inflammation. Their involvement in the development and progression of inflammatory diseases has been subject of intense investigation. Concordantly, the chemokine system has been explored in search for therapeutic targets to prevent or treat inflammatory disorders, such as atherosclerosis. Targeting the chemokine system offers various entry points for a causative treatment of this widespread and chronic illness. Although this approach has encountered some setbacks, several innovative compounds are currently in an advanced stage of development. In this review, the current standing of this dynamic field is highlighted and the potential advantages and drawbacks of particular strategies are discussed.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据